Pneumococcal polysaccharide immunization in infants and children.
about
PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular typeDiversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae.Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).Regulatory T cells in the antibody response to Haemophilus influenzae type b polysaccharideGenetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniaeCross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin a encapsulated in microspheres.Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197.Prevention of pneumococcal infection in children with homozygous sickle cell diseaseAdmissions to hospital of children with sickle-cell anaemia: a study in south LondonThe dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens.Outer membrane protein complex of Meningococcus enhances the antipolysaccharide antibody response to pneumococcal polysaccharide-CRM₁₉₇ conjugate vaccine.Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen.Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniaeOral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse.Serogroups and serotypes of pneumococci in Montreal: correlations with age, outcome and indications for vaccination.Antibiotic-resistant pneumococci in hospitalized children.Characterization of the murine immune response to type 6 pneumococcal polysaccharide.Humoral immune response in chinchillas to the capsular polysaccharides of Streptococcus pneumoniae.Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.Natural killer cell regulation of age-related and type-specific variations in antibody responses to pneumococcal polysaccharides.Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assayDevelopment of the immune systemT cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ CD27+ B cells.A 43-kilodalton pneumococcal surface protein, PspA: isolation, protective abilities, and structural analysis of the amino-terminal sequence.Ability of monophosphoryl lipid A to augment the antibody response of young mice.Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid ADevelopment and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup CEnzyme immunoassay for detection of immunoglobulin G (IgG), IgM, and IgA antibodies against type 6B pneumococcal capsular polysaccharide and cell wall C polysaccharide in chinchilla serumPneumococcal pspA sequence types of prevalent multiresistant pneumococcal strains in the United States and of internationally disseminated clonesAntigen processing of the heptavalent pneumococcal conjugate vaccine carrier protein CRM(197) differs depending on the serotype of the attached polysaccharide.Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children.After chemotherapy, functional humoral response capacity is restored before complete restoration of lymphoid compartments
P2860
Q33513623-DAAD30F8-3C8A-4A25-97EC-970FAFD372C6Q33592652-D3C85476-03AF-4D2F-ADA9-985FA3919DA6Q33975380-372864C5-BA7A-40B5-BD22-1E2932FE5327Q34000337-5A2D2BFD-C661-4901-B0BD-0BBE1845E364Q34008890-846C5F5E-B4EC-44D7-91AD-DE63914193DCQ34120517-55B234F8-A932-4E0B-B919-3C57D6A2CB0FQ34129863-7CC38990-9791-4504-8DBB-FEEB33811806Q34548579-C6DAB185-AD01-41C5-BE55-A522B579F70DQ34778464-11AA3942-E567-4488-A83C-EBE7B5454A70Q34894134-0BB29B75-3832-49A0-AC77-16058A97C3F5Q35066102-28BD9688-8F7C-4D76-BB99-4255EBFB5B40Q35105898-2D3EA3A7-5689-488B-AAC7-B72B0235FA61Q35122158-BC7E4D9E-7F28-42D9-BA0F-922F6398A8C8Q35165275-59B6F25D-00B5-4ECD-9D5B-6ECCC96E182AQ35567265-468D9226-1E3C-4696-AFF2-9813FA790906Q35758346-CA5527F2-E684-4266-9A7D-F20BB8E45D7DQ35807355-87877725-D4D6-44E7-B9EA-24BEE297179CQ36249618-B8216117-4F70-45B3-B633-E1695832D9ACQ36344081-8540575B-0482-41FC-9070-50C0C45E2B41Q36344138-BD2A4613-0BCC-48FA-A837-69BBF02293ADQ36349356-5E7AB89F-A06A-41C9-A976-B232D2DE9C6DQ36353060-662BDB62-7F1E-4E3A-86A0-69B21397C377Q36353317-326CC47C-6B74-40A8-95C0-D1163F7AF62EQ36364180-F860F8AE-D266-4845-8A74-E81B742D57F6Q36454624-4E798B0C-110B-4361-A2CD-6313882F2383Q36625407-2FC1CDB3-6254-4692-A202-28A7364477CAQ36853402-E64B06F5-2B97-4793-AE04-24D679937312Q36962040-9D2FDFE3-64DE-4B72-B56A-17405CD4F0EEQ37001547-BC208337-A7DD-48D8-AE65-AD8195EE284CQ37003695-9011B29F-58B7-44AB-A384-0B9FFA6FBD59Q37003930-55B01CC7-EF32-414E-B3C0-CE1F6F9D7599Q37121761-7DE28986-2C5C-4083-81FF-906B7A3291C0Q39461608-0300CCAD-F446-4514-A1E9-D3203DF64818Q39776822-87C0212D-CA71-4746-9C11-3B648A41057FQ41761101-88648648-BA4D-4EF1-B480-5D5B0F6BE2A8Q57892192-C4504A35-EFB1-4768-A15A-CE8CCCD55EA4
P2860
Pneumococcal polysaccharide immunization in infants and children.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Pneumococcal polysaccharide immunization in infants and children.
@en
Pneumococcal polysaccharide immunization in infants and children.
@nl
type
label
Pneumococcal polysaccharide immunization in infants and children.
@en
Pneumococcal polysaccharide immunization in infants and children.
@nl
prefLabel
Pneumococcal polysaccharide immunization in infants and children.
@en
Pneumococcal polysaccharide immunization in infants and children.
@nl
P2093
P1433
P1476
Pneumococcal polysaccharide immunization in infants and children.
@en
P2093
P304
P407
P577
1978-11-01T00:00:00Z